The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Terenicheva M.A.

A.L. Myasnikov Institute of Clinical Cardioilogy, Russian Cardioilogy Research and Production Complex, Ministry of Health of Russia, Moscow, Russia

Shakhnovich R.M.

A.L. Myasnikov Institute of Clinical Cardioilogy, Russian Cardioilogy Research and Production Complex, Ministry of Health of Russia, Moscow, Russia

Pevsner D.V.

A.L. Myasnikov Institute of Clinical Cardioilogy, Russian Cardioilogy Research and Production Complex, Ministry of Health of Russia, Moscow, Russia

Suhinina T.S.

A.L. Myasnikov Institute of Clinical Cardioilogy, Russian Cardioilogy Research and Production Complex, Ministry of Health of Russia, Moscow, Russia

Zhukova N.S.

A.L. Myasnikov Institute of Clinical Cardioilogy, Russian Cardioilogy Research and Production Complex, Ministry of Health of Russia, Moscow, Russia

Ostroumov E.N.

N.V. Sklifosovsky science and research institute of emergency medicine of Moscow Healthcare Department

Kotina E.D.

St. Petersburg University, Moscow, Russia

The case of acute myocardial damage of patient with pheochromocytoma

Authors:

Terenicheva M.A., Shakhnovich R.M., Pevsner D.V., Suhinina T.S., Zhukova N.S., Ostroumov E.N., Kotina E.D.

More about the authors

Journal: Russian Cardiology Bulletin. 2018;13(3): 52‑59

Read: 2304 times


To cite this article:

Terenicheva MA, Shakhnovich RM, Pevsner DV, Suhinina TS, Zhukova NS, Ostroumov EN, Kotina ED. The case of acute myocardial damage of patient with pheochromocytoma. Russian Cardiology Bulletin. 2018;13(3):52‑59. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20181303152

Recommended articles:
Difficulties of diagnosing a clinically silent pheochromocytoma. Russian Journal of Preventive Medi­cine. 2025;(3):107-111

References:

  1. Lenders J, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665-675. https://doi.org/10.1016/s0140-6736(05)67139-5
  2. Davis M, Bove G. A Case of pheochromocytoma presenting as low back pain. Journal of Manipulative and Physiological Therapeutics. 2007;30(8):598-601. https://doi.org/10.1016/j.jmpt.2007.06.009
  3. Walther MM, Herring J, Enquist E, Keiser HR, Linehan WM. Von Recklinghausen′s disease and pheochromocytomas. The Journal of Urology. 1999;162(5):1582-1586. https://doi.org/10.1016/s0022-5347(05)68171-2
  4. Dluhy R. Pheochromocytoma — death of an axiom. New England Journal of Medicine. 2002;346(19):1486-1488. https://doi.org/10.1056/nejm200205093461911
  5. Stein P, Black H. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institutionʼs experience. Medicine. 1991;70(1):46-66. https://doi.org/10.1097/00005792-199101000-00004
  6. Sohn C. A case of ischemic colitis associated with pheochromocytoma. The American Journal of Gastroenterology. 1998;93(1):124-126. https://doi.org/10.1016/s0002-9270(98)80007-5
  7. Fee H, Fonkalsrud E, Ament M, Bergstein J. Enterocolitis with peritonitis in a child with pheochromocytoma. Annals of Surgery. 1977;185(4):448-450. https://doi.org/10.1097/00000658-197704000-00013
  8. de Leeuw P, Waltman F, Birkenhager W. Noncardiogenic pulmonary edema as the sole manifestation of pheochromocytoma. Hypertension. 1986;8(9):810-812. https://doi.org/10.1161/01.hyp.8.9.810
  9. Naeije R, Yernault J, Goldstein M, Corhil A. Acute pulmonary oedema in a patient with phaeochromocytoma. Intensive Care Medicine. 1978;4(3):165-167. https://doi.org/10.1007/bf01700260
  10. Dagartzikas M, Sprague K, Carter G, Tobias J. Cerebrovascular event, dilated cardiomyopathy, and pheochromocytoma. Pediatric Emergency Care. 2002;18(1):33-35. https://doi.org/10.1097/00006565-200202000-00011
  11. Shemin D. Pheochromocytoma presenting as rhabdomyolysis and acute myoglobinuric renal failure. Archives of Internal Medicine. 1990;150(11):2384. https://doi.org/10.1001/archinte.1990.00390220118024
  12. Januszewicz W, Wocial B. Clinical and biochemical aspects of pheochromocytoma. Cardiology. 1985;72(1):131-136. https://doi.org/10.1159/000173959
  13. Lo C, Lam K, Wat M, Lam K. Adrenal pheochromocytoma remains a frequently overlooked diagnosis. The American Journal of Surgery. 2000;179(3):212-215. https://doi.org/10.1016/s0002-9610(00)00296-8
  14. Whitelaw B, Prague J, Mustafa O, Schulte K, Hopkins P, Gilbert J, McGregor A, Aylwin S. Phaeochromocytoma crisis. Clinical Endocrinology. 2013;80(1):13-22. https://doi.org/10.1111/cen.12324
  15. Zhang R, Gupta D, Albert S. Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature. International Journal of Cardiology. 2017;249:319-323. https://doi.org/10.1016/j.ijcard.2017.07.014
  16. Prejbisz A, Lenders J, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. Journal of Hypertension. 2011;29(11):2049-2060. https://doi.org/10.1097/hjh.0b013e32834a4ce9
  17. Martinez-Quintana E, Jaimes-Vivas R, Cuba-Herrera J, Saiz-Udaeta B, RodrÃguez-Gonzalez F, Martinez-Martin MS. Acute myocardial infarction secondary to catecholamine release owing to cocaine abuse and pheochromocytoma crisis. International Journal of Endocrinology and Metabolism. 2013;11(1):48-51.
  18. Ostroumov EN, Kotina E, Slobodianik V, Tonkoshurova V, Shmirov V, Irishkin O, Shumakov D. Superotvet na serdechnuy resinhronisiruyshuy terapiu i szintigrafia miokarda u bolnih serdechnoj nedostatochnostu. Vrach. 2014;3:50-53. (In Russ.)
  19. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal Supplements. 2014;35(39):2733-2779. https://doi.org/10.1093/eurheartj/ehu284.
  20. Liao W, Liu C, Chiang C, Kung C, Lee C. Cardiovascular manifestations of pheochromocytoma. The American Journal of Emergency Medicine. 2000;18(5):622-625. https://doi.org/10.1053/ajem.2000.7341
  21. Shub C, Cueto-Garcia L, Sheps S, Ilstrup D, Tajik A. Echocardiographic findings in pheochromocytoma. The American Journal of Cardiology. 1986;57(11):971-975. https://doi.org/10.1016/0002-9149(86)90741-1
  22. Galetta F, Franzoni F, Bernini G, Poupak F, Carpi A, Cini G, Tocchini L, Antonelli A, Santoro G. Cardiovascular complications in patients with pheochromocytoma: A mini-review. Biomedicine & Pharmacotherapy. 2010;64(7):505-509. https://doi.org/10.1016/j.biopha.2009.09.014
  23. Lyon A, Bossone E, Schneider B, Sechtem U, Citro R, Underwood S, Sheppard M, Figtree G, Parodi G, Akashi Y, Ruschitzka F, Filippatos G, Mebazaa A, Omerovic E. Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on takotsubosyndrome of the heart failure association of the European Society of Cardiology. European Journal of Heart Failure. 2015;18(1):8-27. https://doi.org/10.1002/ejhf.424
  24. Gagnon N, Mansour S, Bitton Y, Bourdeau I. Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocrine Practice. 2017;23(10):1178-1192. Epub 2017 Jul 13. https://doi.org/10.4158/EP171930.OR
  25. Garg A, Banitt P. Pheochromocytoma and myocardial infarction. Southern Medical Journal. 2004;97(10):981-984. https://doi.org/10.1097/01.smj.0000141310.27872.84
  26. Brouwers F, Lenders J, Eisenhofer G, Pacak K. Pheochromocytomas an endocrine emergency. Reviews in Endocrine and Metabolic Disorders. 2003;4(2):121-128. https://doi.org/10.1023/a:1022981801344
  27. Adameova A, Abdellatif Y, Dhalla N. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. Canadian Journal of Physiology and Pharmacology. 2009;87(7):493-514. https://doi.org/10.1139/y09-042
  28. Pacak K. Preoperative management of the pheochromocytoma patient. The Journal of Clinical Endocrinology & Metabolism. 2007;92(11):4069-4079. https://doi.org/10.1210/jc.2007-1720
  29. Manger WM, Gifford RW. Clinical and Experimental Pheochromocytoma. 2nd ed. Cambridge, 1996.
  30. Paulin FL, Klein GJ, Gula LJ, Skanes AC, Yee R, Krahn AD. QT prolongation and monomorphic VT caused by pheochromocytoma. Journal of Cardiovascular Electrophysiology. 2009;20(8):931-934. https://doi.org/10.1111/j.1540-8167.2008.01405
  31. Leite LR, Macedo PG, Santos SN, Quaglia L, Mesas CE, De Paola A. Life-threatening cardiac manifestations of pheochromocytoma. Case Reports in Medicine. 2010;2010:976120. https://doi.org/10.1155/2010/976120
  32. Sloand E. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Archives of Internal Medicine. 1984;144(1):173. https://doi.org/10.1001/archinte.1984.00350130201036
  33. Eisenhofer G, Timmers H, Lenders J, Bornstein S, Tiebel O, Mannelli M, King K, Vocke C, Linehan W, Bratslavsky G, Pacak K. Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. The Journal of Clinical Endocrinology & Metabolism. 2012;96(2):375-384. https://doi.org/10.1210/jc.2010-1588
  34. Lenders J, Pacak K, Walther M, Linehan W, Mannelli M, Friberg P, Keiser H, Goldstein D, Eisenhofer G. Biochemical diagnosis of pheochromocytoma. JAMA. 2002;287(11):1427-1434. https://doi.org/10.1001/jama.287.11.1427
  35. Khorram-Manesh A, Jansson S, Wangberg B, Nilsson O, Tisell L, Ahlman H. Mortality associated with pheochromocytoma: increased risk for additional tumors. Annals of the New York Academy of Sciences. 2006;1073(1);444-448. https://doi.org/10.1196/annals.1353.048
  36. Huang K, Chung S, Chen S, Chueh S, Pu Y, Lai M, Lin W. Clinical and pathological data of 10 malignant pheochromocytomas: Long-term follow up in a single institute. International Journal of Urology. 2007;14(3):181-185. https://doi.org/10.1111/j.1442-2042.2007.01687.x
  37. Ohji H, Sasagawa I, Iciyanagi O, Suzuki Y, Nakada T. Tumor angiogenesis and Ki-67 expression in phaeochromocytoma. BJU International. 2001;87(4):381-385. https://doi.org/10.1385/EP:15:1:39

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.